PharmaHub · Therapeutics · Middle East & Africa

Gcc Uae Diabetes Devices Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

The Middle East and Africa diabetes devices market encompasses diagnostic and therapeutic equipment used to manage diabetes across the GCC, UAE, and broader regional countries. Valued at approximately $2.53 billion in 2025, the market is expanding at a compound annual growth rate of roughly 6 percent, driven by rising diabetes prevalence, aging populations, and increasing healthcare infrastructure investment. Regional governments are prioritizing non-communicable disease management, while technological advances in continuous glucose monitoring and insulin delivery are accelerating device adoption.

Market size · 2025
$2.5 billion
CAGR · 2025–2030
6.08%
Forecast · 2030
$3.4 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $2.5bn2030 est: $3.4bn
Read the full Gcc Uae Diabetes Devices Market Report report →

Market Overview

The Middle East and Africa diabetes devices market covers blood glucose monitors, insulin pumps, continuous glucose monitoring systems, insulin pens, and related consumables sold across the GCC states, UAE, Levant, and Sub-Saharan Africa. The market was valued at approximately $2.53 billion in 2025 and is projected to reach around $3.10 billion in the near term, with longer-term forecasts extending growth through 2035 at a compound annual rate near 6 percent. This regional market represents a meaningful portion of the global diabetes care devices industry, which is projected to reach roughly $61 billion by 2030.

  • MEA diabetes care devices market estimated at $2.53 billion in 2025, with projected growth to approximately $3.10 billion
  • Broader MEA diabetes industry forecasted at roughly $2.39 billion by 2035 at a 6.08% CAGR
  • GCC and UAE diabetes devices market valued at approximately $3.12 to $3.35 billion in 2024-2025, expected to reach $4.73 billion to $6.84 billion by 2030
  • Global diabetes care devices market projected to reach $61.22 billion by 2030 from $34.30 billion in 2025

Growth Drivers

Rising diabetes prevalence across the Middle East and Africa is the primary catalyst for market expansion, with the region exhibiting some of the highest diabetes rates in the world. Urbanization, sedentary lifestyles, dietary changes, and aging populations are compounding the public health burden and increasing demand for monitoring and treatment devices. Government healthcare modernization programs and national non-communicable disease strategies are expanding insurance coverage and subsidizing device access for patients.

  • High regional diabetes prevalence with growing diagnosed patient populations driving repeat device and consumable purchases
  • Government health initiatives and expanded insurance coverage in GCC countries improving patient access to advanced diabetes management devices
  • Aging demographics and rising obesity rates across MEA countries sustaining long-term demand growth
Want a deeper cut on Gcc Uae Diabetes Devices Market Report? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is typically segmented by product type including blood glucose meters and test strips, insulin pens and needles, insulin pumps, continuous glucose monitoring systems, and diabetes management software. The GCC and UAE sub-region represents the most mature and highest-value segment of the MEA market due to higher healthcare spending, developed infrastructure, and greater adoption of premium devices. Other MEA countries are growing faster in percentage terms but from a smaller installed base, with penetration of advanced devices still lagging behind GCC markets.

  • Blood glucose monitoring devices constitute the largest product segment, followed by insulin delivery devices including pens and pumps
  • GCC and UAE account for the dominant share of regional market value due to higher per-capita healthcare expenditure
  • Africa outside the GCC represents a smaller but faster-growing segment as basic diabetes care access expands

Trends and Outlook

What are the recent trends and outlook?

Shift toward minimally invasive and connected diabetes management technologies is accelerating, with continuous glucose monitoring and smart insulin pumps seeing rapidly increasing adoption in GCC markets. Integration of digital health platforms, mobile applications, and telemedicine services is creating new touchpoints for patient engagement and remote monitoring. Over the forecast horizon through 2030 and beyond, market growth will depend on continued device innovation, pricing affordability for broader population segments, and sustained government investment in diabetes care infrastructure across the region.

  • Growing adoption of continuous glucose monitoring and hybrid closed-loop insulin delivery systems replacing traditional finger-stick testing
  • Digital health integration and remote patient monitoring tools gaining traction with healthcare systems across GCC countries
  • Market expansion contingent on improving device affordability and access in lower-income MEA countries
Talk to a Claight analyst
Do you want to research Gcc Uae Diabetes Devices Market Report?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.